For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million
Enlarge / Heather Bresch, chief executive officer of Mylan.Getty | Bloomberg reader comments 5 Share this story In a settlement announced Friday, Mylan, Inc., the maker of EpiPens, will shell out $465 million to the Department of Justice and other federal agencies to brush aside any questions about its Medicaid rebates. Further ReadingFeds go after...
I regard the brain as a computer which will stop working when its component fail. There is no heaven or afterlife for broken-down computers. That is a fairy story for people afraid of the dark